CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Quipt Home Medical Corp. - QIPT CFD

    3.43
    0.87%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    Trading сonditions
    Spread 0.05
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026179 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026179%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003957 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003957%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 3.46
    Open* 3.44
    1-Year Change* -43.7%
    Day's Range* 3.4 - 3.47
    52 wk Range 5.77-9.75
    Average Volume (10 days) 29.89K
    Average Volume (3 months) 613.94K
    Market Cap 259.81M
    P/E Ratio -100.00K
    Shares Outstanding 42.10M
    Revenue 299.02M
    EPS -0.09
    Dividend (Yield %) N/A
    Beta 1.03
    Next Earnings Date Feb 12, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Apr 18, 2024 3.46 -0.12 -3.35% 3.58 3.58 3.45
    Apr 17, 2024 3.58 -0.11 -2.98% 3.69 3.70 3.56
    Apr 16, 2024 3.66 -0.10 -2.66% 3.76 3.76 3.65
    Apr 15, 2024 3.75 -0.03 -0.79% 3.78 3.80 3.75
    Apr 12, 2024 3.82 -0.06 -1.55% 3.88 3.92 3.78
    Apr 11, 2024 3.91 -0.02 -0.51% 3.93 3.96 3.90
    Apr 10, 2024 3.93 -0.02 -0.51% 3.95 3.95 3.85
    Apr 9, 2024 3.99 -0.04 -0.99% 4.03 4.03 3.98
    Apr 8, 2024 4.02 -0.04 -0.99% 4.06 4.06 4.01
    Apr 5, 2024 4.03 -0.02 -0.49% 4.05 4.05 4.01
    Apr 4, 2024 4.07 -0.04 -0.97% 4.11 4.21 4.06
    Apr 3, 2024 4.17 -0.01 -0.24% 4.18 4.20 4.09
    Apr 2, 2024 4.19 -0.04 -0.95% 4.23 4.33 4.18
    Apr 1, 2024 4.34 0.01 0.23% 4.33 4.34 4.26
    Mar 28, 2024 4.33 0.03 0.70% 4.30 4.39 4.30
    Mar 27, 2024 4.31 0.07 1.65% 4.24 4.31 4.24
    Mar 26, 2024 4.29 0.09 2.14% 4.20 4.30 4.20
    Mar 25, 2024 4.29 0.01 0.23% 4.28 4.32 4.21
    Mar 22, 2024 4.28 0.00 0.00% 4.28 4.30 4.15
    Mar 21, 2024 4.28 0.07 1.66% 4.21 4.31 4.20

    Quipt Home Medical Corp. Events

    Time (UTC) Country Event
    Tuesday, May 14, 2024

    Time (UTC)

    12:30

    Country

    CA

    Event

    Q2 2024 Quipt Home Medical Corp Earnings Release
    Q2 2024 Quipt Home Medical Corp Earnings Release

    Forecast

    -

    Previous

    -
    Monday, August 12, 2024

    Time (UTC)

    10:59

    Country

    CA

    Event

    Q3 2024 Quipt Home Medical Corp Earnings Release
    Q3 2024 Quipt Home Medical Corp Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 139.862 102.351 72.639 59.5477 51.86
    Revenue 139.862 102.351 72.639 59.5477 51.86
    Cost of Revenue, Total 33.213 28.172 19.934 16.6088 15.9866
    Gross Profit 106.649 74.179 52.705 42.9389 35.8734
    Total Operating Expense 135.412 103.811 71.981 63.7641 56.7066
    Selling/General/Admin. Expenses, Total 63.735 4.952 0.171 1.51725 29.8073
    Depreciation / Amortization 23.04 17.786 14.538 10.2736 11.1024
    Unusual Expense (Income) 1.123 0.139 0.015 3.29631 -0.20078
    Other Operating Expenses, Total 14.301 52.762 37.323 32.0681 0.011032
    Operating Income 4.45 -1.46 0.658 -4.21637 -4.84666
    Interest Income (Expense), Net Non-Operating -1.835 -4.278 -1.586 -1.26131 -1.27896
    Other, Net 0.32 -3.591 -2.647 -1.04729 0
    Net Income Before Taxes 2.935 -9.329 -3.575 -6.52497 -6.12562
    Net Income After Taxes 4.839 -6.174 -3.703 -6.72281 -6.22122
    Net Income Before Extra. Items 4.839 -6.174 -3.703 -6.72281 -6.22122
    Net Income 4.839 -6.174 -4.572 -5.43208 13.7876
    Income Available to Common Excl. Extra. Items 4.839 -6.174 -3.703 -6.72281 -6.22122
    Income Available to Common Incl. Extra. Items 4.839 -6.174 -4.572 -5.43208 13.7876
    Dilution Adjustment
    Diluted Net Income 4.839 -6.174 -4.572 -5.43208 13.7876
    Diluted Weighted Average Shares 36.302 30.438 22.721 20.715 18.8542
    Diluted EPS Excluding Extraordinary Items 0.1333 -0.20284 -0.16298 -0.324535 -0.329962
    Dividends per Share - Common Stock Primary Issue
    Diluted Normalized EPS 0.15341 -0.19987 -0.16255 -0.221108 -0.336883
    Total Extraordinary Items 0 -0.869 1.29073 20.0088
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 60.284 58.12 40.815 40.092 36.692
    Revenue 60.284 58.12 40.815 40.092 36.692
    Total Operating Expense 60.114 56.839 39.441 39.523 36.073
    Selling/General/Admin. Expenses, Total 23.5 23.142 16.205 17.29 16.426
    Depreciation / Amortization 11.698 9.581 6.793 7.205 5.363
    Unusual Expense (Income) -0.058 0.875 0.257 0.91 0.149
    Other Operating Expenses, Total 8.344 8.332 6.111 4.824 5.229
    Operating Income 0.17 1.281 1.374 0.569 0.619
    Interest Income (Expense), Net Non-Operating -1.527 -2.03 -0.716 -0.456 -0.385
    Other, Net 0 0 0 -0.705 0.084
    Net Income Before Taxes -1.357 -0.749 0.658 -0.592 0.318
    Net Income After Taxes -1.034 -0.749 0.325 1.77 0.163
    Net Income Before Extra. Items -1.034 -0.749 0.325 1.77 0.163
    Total Extraordinary Items
    Net Income -1.034 -0.749 0.325 1.77 0.163
    Income Available to Common Excl. Extra. Items -1.034 -0.749 0.325 1.77 0.163
    Income Available to Common Incl. Extra. Items -1.034 -0.749 0.325 1.77 0.163
    Diluted Net Income -1.034 -0.749 0.325 1.77 0.163
    Diluted Weighted Average Shares 40.584 35.858 38.148 34.241 37.863
    Diluted EPS Excluding Extraordinary Items -0.02548 -0.02089 0.00852 0.05169 0.0043
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.02641 0.00351 0.01185 0.06897 0.00632
    Cost of Revenue, Total 16.63 14.909 10.075 9.294 8.906
    Gross Profit 43.654 43.211 30.74 30.798 27.786
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 41.536 57.233 45.283 23.247 16.9023
    Cash and Short Term Investments 8.516 34.612 29.227 9.708 3.18526
    Cash 8.516 34.612 29.227 9.708 3.18526
    Total Receivables, Net 16.383 11.938 9.089 9.357 9.20938
    Accounts Receivable - Trade, Net 16.383 11.938 9.089 9.357 9.20938
    Total Inventory 15.585 9.253 6.415 3.578 4.14797
    Prepaid Expenses 1.052 1.43 0.552 0.604 0.359638
    Total Assets 132.214 108.573 72.065 41.659 36.1146
    Property/Plant/Equipment, Total - Net 33.497 23.506 16.667 14.723 15.3622
    Goodwill, Net 28.208 12.456 3.895 1.42 1.3525
    Intangibles, Net 28.887 14.874 5.579 2.198 2.40862
    Other Long Term Assets, Total 0.086 0.504 0.641 0.071 0.08899
    Total Current Liabilities 41.74 32.737 24.385 15.919 13.5287
    Accounts Payable 13.841 9.842 7.434 6.134 4.62749
    Accrued Expenses 3.451 3.202 3.488 1.75 1.72832
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 15.634 14.858 8.947 6.597 7.10304
    Other Current Liabilities, Total 8.814 4.835 4.516 1.438 0.069868
    Total Liabilities 52.667 49.951 43.83 28.636 21.9423
    Total Long Term Debt 10.927 17.081 18.885 12.717 8.41362
    Long Term Debt 3.732 12.297 15.655 11.677 8.41362
    Deferred Income Tax
    Total Equity 79.547 58.622 28.235 13.023 14.1722
    Common Stock 214.254 203.484 168.089 151.963 142.643
    Additional Paid-In Capital 26.317 21.001 16.648 16.177 14.0038
    Retained Earnings (Accumulated Deficit) -161.024 -165.863 -166.554 -155.117 -151.544
    Other Equity, Total 10.052 9.06965
    Total Liabilities & Shareholders’ Equity 132.214 108.573 72.065 41.659 36.1146
    Total Common Shares Outstanding 35.605 33.35 28.0693 20.897 18.9548
    Other Liabilities, Total 0 0.133 0.56 0 0
    Property/Plant/Equipment, Total - Gross 57.147 45.051 31.411 31.807
    Accumulated Depreciation, Total -23.65 -21.545 -16.688 -16.4448
    Capital Lease Obligations 7.195 4.784 3.23 1.04
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total Current Assets 66.899 49.492 38.955 41.536 47.335
    Cash and Short Term Investments 20.445 2.087 3.656 8.516 18.538
    Cash 20.445 2.087 3.656 8.516 18.538
    Total Receivables, Net 23.817 25.166 17.178 16.383 14.864
    Accounts Receivable - Trade, Net 23.817 25.166 17.178 16.383 14.864
    Total Inventory 19.449 20.377 16.866 15.585 13.239
    Prepaid Expenses 3.188 1.862 1.255 1.052 0.694
    Total Assets 242.385 225.543 131.725 132.214 130.478
    Property/Plant/Equipment, Total - Net 51.401 52.042 36.393 33.497 29.666
    Property/Plant/Equipment, Total - Gross 57.147
    Accumulated Depreciation, Total -23.65
    Goodwill, Net 50.85 50.725 28.208 28.208 34.576
    Intangibles, Net 72.961 73.042 28.086 28.887 18.498
    Other Long Term Assets, Total 0.274 0.242 0.083 0.086 0.403
    Total Current Liabilities 55.767 68.17 37.1 41.74 46.479
    Accounts Payable 24.373 23.433 14.128 13.841 13.191
    Accrued Expenses 5.329 5.708 2.427 3.451 2.52
    Notes Payable/Short Term Debt 0 0 0 0 12
    Current Port. of LT Debt/Capital Leases 21.255 31.743 12.488 15.634 9.137
    Other Current Liabilities, Total 4.81 7.286 8.057 8.814 9.631
    Total Liabilities 131.401 143.741 51.282 52.667 62.753
    Total Long Term Debt 75.634 75.571 14.182 10.927 16.274
    Long Term Debt 62.072 63.185 3.983 3.732 10.091
    Capital Lease Obligations 13.562 12.386 10.199 7.195 6.183
    Other Liabilities, Total 0 0
    Total Equity 110.984 81.802 80.443 79.547 67.725
    Common Stock 247.444 219.206 214.254 214.254 205.1
    Additional Paid-In Capital 26.024 24.045 26.888 26.317 25.419
    Retained Earnings (Accumulated Deficit) -162.484 -161.449 -160.699 -161.024 -162.794
    Total Liabilities & Shareholders’ Equity 242.385 225.543 131.725 132.214 130.478
    Total Common Shares Outstanding 42.073 36.613 35.605 35.605 33.647
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 4.839 -6.174 -3.703 -6.90773 -6.39235
    Cash From Operating Activities 26.344 18.692 14.034 8.39266 10.393
    Cash From Operating Activities 23.04 17.786 14.538 10.5562 11.4078
    Deferred Taxes -3.8 0
    Non-Cash Items 0.367 19.756 7.818 8.56797 9.65238
    Changes in Working Capital -1.902 -8.876 -4.619 -3.82377 -4.27492
    Cash From Investing Activities -42.493 -17.838 -7.853 2.97514 -0.706567
    Capital Expenditures -9.161 -5.046 -0.091 -0.154916 -0.517645
    Other Investing Cash Flow Items, Total -33.332 -12.792 -7.762 3.13005 -0.188922
    Cash From Financing Activities -9.851 3.91 13.721 -5.03136 -10.2637
    Financing Cash Flow Items -4.917 -1.274 5.437 -1.19625 -2.22625
    Issuance (Retirement) of Stock, Net 0.567 19.077 21.254 3.16481 0.190433
    Issuance (Retirement) of Debt, Net -5.501 -13.893 -12.97 -6.99992 -8.22791
    Foreign Exchange Effects -0.096 0.621 -0.383 0.10504 1.28769
    Net Change in Cash -26.096 5.385 19.519 6.44147 0.710345
    Cash Taxes Paid 0.653
    Cash Interest Paid 2.007
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -0.425 0.325 4.839 3.069 2.905
    Cash From Operating Activities 14.816 4.832 26.344 19.433 12.193
    Cash From Operating Activities 16.376 6.793 23.04 15.835 10.473
    Deferred Taxes 0
    Non-Cash Items 4.981 1.62 0.367 1.144 4.331
    Changes in Working Capital -6.116 -3.906 -1.902 -0.615 -5.516
    Cash From Investing Activities -77.6 -1.301 -42.493 -34.424 -19.941
    Capital Expenditures -4.937 -1.301 -9.161 -6.02 -3.683
    Other Investing Cash Flow Items, Total -72.663 0 -33.332 -28.404 -16.258
    Cash From Financing Activities 56.366 -8.388 -9.851 -0.985 -9.553
    Financing Cash Flow Items -3.775 -0.823 -4.917 -1.468 -1.182
    Issuance (Retirement) of Stock, Net 0.081 0 0.567 0.554 0.024
    Issuance (Retirement) of Debt, Net 60.06 -7.565 -5.501 -0.071 -8.395
    Foreign Exchange Effects -0.011 -0.003 -0.096 -0.098 0.083
    Net Change in Cash -6.429 -4.86 -26.096 -16.074 -17.218
    Cash Taxes Paid 0.515 0 0.653 0.468
    Cash Interest Paid 2.441 0.595 2.007 1.52

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Quipt Home Medical Corp. Company profile

    About Quipt Home Medical Corp

    Quipt Home Medical Corp, formerly Protech Home Medical Corp., is a healthcare service company. The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. Its offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The Company’s products and services includes sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aides, respiratory equipment rentals, and oxygen therapies. Its sleep apnea and pap treatment consists of sleep testing system to allow their patients to test at home. Its home ventilation services include Invasive and Non-Invasive ventilator treatments. The Company rents a range of respiratory therapy equipment for adult and pediatric respiratory care.

    Financial summary

    BRIEF: For the three months ended 31 December 2021, Quipt Home Medical Corp revenues increased 30% to $29.5M. Net loss totaled $2.1M vs. income of $1.4M. Revenues reflect Sales of medical equipment and supplies increase of 40% to $14.5M, Rentals of medical equipment increase of 21% to $15M. Net loss reflects Operating expenses increase of 37% to $15.8M (expense), Stock-based compensation increase from $15K to $2.1M (expense).

    Equity composition

    10 for 1 stock split on September 30 2008.

    Industry: Healthcare Facilities & Services (NEC)

    1019 Town Drive
    WILDER
    KENTUCKY 41076
    US

    Income Statement

    • Annual
    • Quarterly

    News

    Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

    Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

    07:56, 17 April 2024

    US Earnings Season : JP Morgan, Citigroup, Wells Fargo

    The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

    16:03, 11 April 2024

    Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

    The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

    09:22, 11 April 2024

    US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

    US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

    15:11, 9 April 2024

    How escalating geopolitical tensions are impacting oil markets

    The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

    13:34, 4 April 2024

    A way forward: a roundup of recent central bank decisions

    Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

    12:47, 22 March 2024

    Bank of Japan Preview: will the BOJ end negative interest rates?

    The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

    08:44, 18 March 2024

    People also watch

    ETH/USD

    3,059.32 Price
    -0.510% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 6.00

    Gold

    2,392.09 Price
    +0.540% 1D Chg, %
    Long position overnight fee -0.0192%
    Short position overnight fee 0.0110%
    Overnight fee time 21:00 (UTC)
    Spread 0.40

    XRP/USD

    0.51 Price
    +0.990% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01168

    BTC/USD

    63,910.85 Price
    +0.370% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 610,000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading